Gene · 57045
Papers1,736
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,736
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| De novo pyrimidine synthesis is a collateral metabolic vulnerability in NF2-deficient mesothelioma. | EMBO Mol Med | 2025 | 40707702 | PubTator, text mining | PubMed |
| REPS2 attenuates cancer stemness through inhibiting Wnt signaling by autophagy mediated degradation of β-catenin. | Oncogene | 2025 | 40514427 | PubTator, text mining | PubMed |
Integrating Aggressive-Variant Prostate Cancer-Associated Tumor Suppressor Gene Status with Clinical Variables to Refine Prognosis and Predict Androgen Receptor Pathway Inhibitor Response in Metastatic Hormone-Sensitive Setting. | Int J Mol Sci | 2025 | 40508118 | PubTator, text mining | PubMed |
| Short Videos Turn Everyone into Bearers of Traditional Sports and Games: A Mixed-Methods Study from China. | Behav Sci (Basel) | 2025 | 40426415 | PubTator, text mining | PubMed |
| Silencing of SCEL promotes progression of oral squamous cell carcinoma via activating TGF-β/Smad pathway. | Discov Oncol | 2025 | 40372539 | PubTator, text mining | PubMed |
| Chemopreventive and therapeutic effects of Hippophae rhamnoides L. fruit peels evaluated in preclinical models of breast carcinoma. | Front Pharmacol | 2025 | 40371330 | PubTator, text mining | PubMed |
| The Role of Twisted Gastrulation 1 (TWSG1) Gene in TGF-β Signaling Linked to Cancer: A Comprehensive Review. | Asian Pac J Cancer Prev | 2025 | 40302064 | PubTator, text mining | PubMed |
| Role of tumor suppressor genes P53 and PTEN in CD44-mediated gastric adenocarcinoma multidrug resistance. | Biomed Pharmacother | 2025 | 40280031 | PubTator, text mining | PubMed |
| Exploring the Genetic Orchestra of Cancer: The Interplay Between Oncogenes and Tumor-Suppressor Genes. | Cancers (Basel) | 2025 | 40227591 | PubTator, text mining | PubMed |
| The impact of co-occurring tumor suppressor mutations with mEGFR as early indicators of relapse in lung cancer. | ESMO Open | 2025 | 40088801 | PubTator, text mining | PubMed |
| The Emerging Predictive and Prognostic Role of Aggressive-Variant-Associated Tumor Suppressor Genes Across Prostate Cancer Stages. | Int J Mol Sci | 2025 | 39796175 | PubTator, text mining | PubMed |
| Triple Combination of MEK, BET, and CDK Inhibitors Significantly Reduces Human Malignant Peripheral Nerve Sheath Tumors in Mouse Models. | Clin Cancer Res | 2025 | 39786423 | PubTator, text mining | PubMed |
| Collateral lethality: A unique type of synthetic lethality in cancers. | Pharmacol Ther | 2025 | 39581504 | PubTator, text mining | PubMed |
| Precise Methylation Detection of Tumor Suppressor Gene Promoters by Magnetic Enrichment and Nano Silver Adduct-Promoted Surface-Enhanced Raman Scattering. | Small | 2025 | 39520342 | PubTator, text mining | PubMed |
| Innovative Low-cost Probe Generation Empowers Targeted Long-read RNA Sequencing. | Genomics Proteomics Bioinformatics | 2025 | 39436220 | PubTator, text mining | PubMed |
| Study of the Immune Infiltration and Sonic Hedgehog Expression Mechanism in Synovial Tissue of Rheumatoid Arthritis-Related Interstitial Lung Disease under Machine Learning CIBERSORT Algorithm. | Mol Biotechnol | 2025 | 39110383 | PubTator, text mining | PubMed |
| Genomic insights into Neolithic founding paternal lineages around the Qinghai-Xizang Plateau using integrated YanHuang resource. | iScience | 2024 | 39759003 | PubTator, text mining | PubMed |
| Prognostic Expression Signature of RB1, PTEN, and TP53 Genes in Patients with Metastatic Hormone-sensitive Prostate Cancer Treated with Androgen Receptor Pathway Inhibitors. | Eur Urol Open Sci | 2024 | 39502104 | PubTator, text mining | PubMed |
| Protein structural context of cancer mutations reveals molecular mechanisms and candidate driver genes. | Cell Rep | 2024 | 39441719 | PubTator, text mining | PubMed |
| Identification and validation of an m7G-related lncRNAs signature for predicting prognosis, immune response and therapy landscapes in ovarian cancer. | Front Genet | 2024 | 39440245 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57045/papers?page=3